Investors of Semler Corporation are reminded of the approaching Class Action lawsuit, with the Lead Plaintiff deadline set for October 28, 2025, as stated by Faruqi & Faruqi.
Semler Scientific, a company listed on NASDAQ with the ticker symbol SMLR, is currently under investigation by the United States Department of Justice (DOJ) for alleged violations of federal securities laws and the False Claims Act.
The DOJ's investigation is the focus of the investigation being carried out by Faruqi & Faruqi, LLP, a leading national securities law firm. The firm is investigating potential claims against Semler Scientific, Inc. The complaint alleges that the company did not disclose a material investigation by the DOJ into violations of the False Claims Act.
Additionally, the complaint alleges that Semler Scientific's public statements were materially false and/or misleading. This could potentially lead to the DOJ filing a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages against Semler Scientific.
In response to the investigation, Semler Scientific filed its 2024 annual report on Form 10-K after trading hours on February 28, 2025, which disclosed initial settlement discussions with the DOJ that were ceased. However, the company does not believe the amount of loss can be reasonably estimated at this time.
For investors who wish to take part in the ongoing legal proceedings, October 28, 2025, is the deadline for investors to seek the role of lead plaintiff in a federal securities class action against Semler Scientific. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice. The court-appointed lead plaintiff in the class action is the investor with the largest financial interest in the relief sought by the class.
Interested parties can learn more about the Semler Scientific class action at www.faruqilaw.com/SMLR. Faruqi & Faruqi, LLP encourages anyone with information regarding Semler Scientific’s conduct to contact the firm.
It is important to note that Semler Scientific's stock fell over 9% on the next trading day following the news. Investors who choose not to serve as lead plaintiff will not be affected in their ability to share in any recovery.
A photo accompanying this announcement is available at https://www.our website/NewsRoom/AttachmentNg/3a3fa937-87cb-45e3-b706-966046064eee.
Faruqi & Faruqi, LLP can be found on LinkedIn, X, and Facebook. For further information or to contact Faruqi & Faruqi partner Josh Wilson, please call 877-247-4292 or 212-983-9330 (Ext. 1310). The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames